HomeInsightsStock Comparison

Medico Remedies Ltd vs Remus Pharmaceuticals Ltd Stock Comparison

Medico Remedies Ltd vs Remus Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 19, 2025

Key Highlights

  • The Latest Trading Price of Medico Remedies Ltd is ₹ 39.35 as of 18 Jul 15:30.
  • The P/E Ratio of Medico Remedies Ltd is 0 as of March 2024 .The P/E Ratio of Remus Pharmaceuticals Ltd is 47.2 as of March 2024.
  • The Market Cap of Medico Remedies Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Remus Pharmaceuticals Ltd is ₹ 1016 crore as of March 2024.
  • The revenue of Medico Remedies Ltd for the Mar '25 is ₹ 41.6 crore as compare to the Dec '24 revenue of ₹ 40.91 crore. This represent the growth of 1.69% The revenue of Remus Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Medico Remedies Ltd for the Mar '25 is ₹ 6.96 crore as compare to the Dec '24 ebitda of ₹ 4.54 crore. This represent the growth of 53.3% The ebitda of Remus Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Medico Remedies Ltd changed from ₹ 1.32 crore to ₹ 4.34 crore over 8 quarters. This represents a CAGR of 81.33% The net profit of Remus Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Medico Remedies Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2023 to 3.5 % on March 2024 . This represents a CAGR of 16.93% over 2 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Medico Remedies Ltd

  • Medico Remedies Limited was incorporated as a Private Limited Company with the name 'Medico Remedies Private Limited' on March 18, 1994.
  • The status was changed to a Public Limited Company and the Company name was changed to Medico Remedies Limited on March 6, 2017. Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements.
  • Further in addition to above, the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, Antihistaminic, Antidiabetics, Cardio Vascular Drugs, Diuretics, Anti-Epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.

About Remus Pharmaceuticals Ltd

  • Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
  • Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
  • It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
  • The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

Medico Remedies Ltd News Hub

News

Medico Remedies announces board meeting date

Medico Remedies will hold a meeting of the Board of Directors of the Company on 8 May 2025...

Read more

02 May 2025 12:08

News

Medico Remedies wins order of USD 1.9 million from Dominican Republic

Medico Remedies has secured government supply order for USD 1.9 million to supply to Domin...

Read more

09 Apr 2025 10:03

News

Medico Remedies gains after securing Rs 16-cr supply order

The company will supply tablets, capsules, and dry syrups, with the completion expected wi...

Read more

08 Apr 2025 15:26

News

Medico Remedies Ltd leads losers in 'B' group

Swelect Energy Systems Ltd, Khandwala Securities Ltd, Asian Energy Services Ltd and Centur...

Read more

27 Feb 2025 14:45

News

Medico Remedies to convene board meeting

Medico Remedies will hold a meeting of the Board of Directors of the Company on 5 February...

Read more

31 Jan 2025 11:15

News

Medico Remedies to discuss results

Medico Remedies will hold a meeting of the Board of Directors of the Company on 12 Novembe...

Read more

09 Nov 2024 11:16

Remus Pharmaceuticals Ltd News Hub

News

Board of Remus Pharmaceuticals recommends final dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

19 May 2025 09:57

News

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 17 M...

Read more

13 May 2025 16:52

News

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

09 Nov 2024 16:57

News

Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

07 Nov 2024 10:21

News

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

31 Aug 2024 15:40

News

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...

Read more

10 May 2024 12:07

SWOT Analysis Of Medico Remedies Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Remus Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Medico Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Remus Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Medico Remedies Ltd and Remus Pharmaceuticals Ltd

Which company has a larger market capitalization, Medico Remedies Ltd or Remus Pharmaceuticals Ltd?

Market cap of Medico Remedies Ltd is 326 Cr while Market cap of Remus Pharmaceuticals Ltd is 1,153 Cr

What are the key factors driving the stock performance of Medico Remedies Ltd and Remus Pharmaceuticals Ltd?

The stock performance of Medico Remedies Ltd and Remus Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medico Remedies Ltd and Remus Pharmaceuticals Ltd?

As of July 19, 2025, the Medico Remedies Ltd stock price is INR ₹39.35. On the other hand, Remus Pharmaceuticals Ltd stock price is INR ₹978.75.

How do dividend payouts of Medico Remedies Ltd and Remus Pharmaceuticals Ltd compare?

To compare the dividend payouts of Medico Remedies Ltd and Remus Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions